A prospective, single-center, observational study aiming to assess the predictive role of flow mediated dilatation in acute coronary syndromes, combined with echocardiographic and biochemical indices. The novel Cor-IS technology will also be evaluated.
Age > 18 years
Patients hospitalized due to acute coronary syndrome (STEMI, NSTEMI)
Capability of providing written informed consent
Patients able to comply with the follow-up schedule of the study
Patients with acute coronary syndromes classified as MINOCA, or type II myocardial infarction
Patients with rare acute coronary syndrome types, such as spontaneous coronary artery dissection or Takotsubo syndrome
Patients with congenital heart disease
Age > 85 years